NSAIDs & Alzheimer’s
This article was originally published in The Tan Sheet
In vitro studies of naproxen and ibuprofen in a post-mortem brain afflicted with Alzheimer's disease "indicate for the first time the binding of select NSAIDs to plaques" that may cause the disease, researchers say in March 31 Neuroscience. Jorge Barrio, PhD, UCLA, et al., note findings may lead to improving plaque anti-aggregation in experimental drugs. Authors are planning 30-patient, six-month to year-long in vivo trial to begin soon...
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.